Abstract: The present invention relates to a novel fused ring compound having urea structure that exhibits excellent NAMPT activating effect, and a method using the same for treating/preventing metabolic disorder, cardiovascular and kidney disease, mitochondrial disease, neurodegenerative disease, ocular disease, and muscle wasting disorder. The present invention provides a compound represented by following formula (I) or a pharmacologically acceptable salt: wherein A, B, R1, R2 and R3 represent the same meanings as in the claims.

Abstract: The culture insert container has a lower culture container having a bottom portion equipped with a porous membrane and a sidewall, and having an upper insertion fixture having a cylindrical sidewall that is inserted into said lower culture container. The cylindrical sidewall has a land arranged so as to protrude from a top end of the sidewall of the lower culture container at a location such as will cause a top surface of said porous membrane and a bottom end portion of the cylindrical sidewall which is inserted within the lower culture container to be maintained in a noncontacting state. A land is arranged at an outer surface of the cylindrical sidewall so as to cause a constant distance to be maintained between an inner surface of the sidewall of the lower culture container and the outer surface of the cylindrical sidewall.

Abstract: A light source device includes a substrate, a laser element on a main surface of the substrate and configured to emit laser light, an optical element on the main surface of the substrate and in an optical path of the laser light, and a polarization element on the optical element. The optical element has a first surface that reflects in a first direction a first component of the laser light incident onto the optical element from the laser element, and a second surface that reflects in the first direction a second component of the laser light incident onto the optical element from the laser element and transmitted through the first surface. The first component of the laser light reflected by the first surface is not transmitted through the polarization element and the second component of the laser light reflected by the second surface is transmitted through the polarization element.

Abstract: A vehicle hood assembly can include a vehicle body structure and a hood moveable with respect to the vehicle body structure from a closed state to an opened state. A first linkage can connect the hood to the vehicle body structure and include a first linkage aperture extending therethrough. A second linkage can connect the hood to the vehicle body structure and include a second linkage aperture extending therethrough. A central axis of the first linkage aperture can be coaxial with a central axis of the second linkage aperture if the hood is in the opened state. A key structure can be provided and configured to simultaneously fit into both the second linkage aperture and the first linkage aperture if the hood is in the opened state.

Abstract: Provided is a semiconductor device comprising a semiconductor substrate having an upper surface and a lower surface, with a bulk donor distributed between the upper surface and the lower surface, that has a drift region of a first conductivity type provided thereon, the semiconductor device comprising a high-concentration region of a first conductivity type that is arranged between the drift region and the lower surface of the semiconductor substrate, includes a hydrogen donor, and has a carrier concentration that is higher than a bulk donor concentration, wherein the high-concentration region has a first portion in which a hydrogen donor concentration obtained by subtracting a bulk donor concentration from a carrier concentration is 7×1013/cm3 or more and 1.5×1014/cm3 or less, and a length of the first portion in a depth direction of the semiconductor substrate is 50% or more of a length of the high-concentration region.

Abstract: A hood for a vehicle is movable between an open position and a closed position for covering a vehicle compartment. The hood includes a hood body having an exterior facing surface and an interior facing surface. A first bracket attached to the interior facing surface of the hood body includes a bottom end having a downward opening slot a rotatable hinge attached to the vehicle in the vehicle compartment for moving the hood body between the open position and the closed position. A second bracket is attached to the vehicle in the vehicle compartment. The second bracket is attached to a distal end of the rotatable hinge and includes a weld stud extending laterally from a side of the second bracket. The first bracket is seated on the weld stud during installation of the hood.

Abstract: The present invention relates to a novel fused ring compound having urea structure that exhibits excellent NAMPT activating effect, and a method using the same for treating/preventing metabolic disorder, cardiovascular and kidney disease, mitochondrial disease, neurodegenerative disease, ocular disease, and muscle wasting disorder. The present invention provides a compound represented by following formula (I) or a pharmacologically acceptable salt: wherein A, B, R1, R2 and R3 represent the same meanings as in the claims.

Abstract: The present invention relates to a novel azole derivative as an apelin receptor agonist and a method for treating cardiovascular disease, diabetic disease, renal disease, hypertension, and arteriosclerosis, etc., using the same. The present invention provides a compound represented by formula (I) or a pharmacologically acceptable salt thereof wherein X1 represents —N? or —CH?, X2 represents —CH? or —N?, R1 and R2 each represent a C1 to C6 alkoxy group or the like, R3 represents a heteroaryl group (the heteroaryl group is optionally substituted by a methyl group or the like) or the like, and R4 represents a C1 to C6 alkylthio group or a C2 to C6 alkenyl group (the C1 to C6 alkylthio group and the C2 to C6 alkenyl group are each optionally substituted by one carboxy group or the like) or the like.

Abstract: Provided is a semiconductor module including a plurality of SiC chips electrically connected in parallel and each having a MOSFET and a parasitic transistor formed therein, and a control unit which controls switching of the MOSFET in each of the SiC chips, and for all of the plurality of SiC chips, at least in a state where the parasitic transistor is turned on, the control unit controls, to 0.9 ?s or less, a turn-off time of the MOSFET corresponding.

Abstract: A method for manufacturing a semiconductor substrate, including: applying a composition for forming a resist underlayer film directly or indirectly to a substrate to form a resist underlayer film directly or indirectly on the substrate; forming a resist pattern directly or indirectly on the resist underlayer film; and performing etching using the resist pattern as a mask. The composition for forming a resist underlayer film contains: a polymer having a repeating unit represented by formula (1) and a solvent. Ar1 is a divalent group including an aromatic ring having 5 to 40 ring atoms; and R0 is a monovalent group including an aromatic ring having 5 to 40 ring atoms and includes at least one group selected from the group consisting of groups represented by formula (2-1) and groups represented by formula (2-2).

Abstract: An inventory management system has an inventory management device and a terminal device, and the inventory management device includes an inventory status generation unit configured to generate information indicating an inventory status of a medical device for each of medical institutions, by referring to a required inventory storage unit storing information indicating a required inventory quantity of the medical device for each of the medical institutions, and a state management storage unit storing state management information associating a unique ID of the medical device dispatched to one medical institution with a collection status of the medical device paid out from the one medical institution to a patient for each of the medical institutions, and an output unit configured to output the information indicating the inventory status to the terminal device.

Abstract: To provide a hair growth agent and a scalp care agent which are topical agents that exhibit scalp care effect as well as effect in terms of causing increase in hair shaft diameter and effect in terms of improving maximum hair shaft length and improving hair shaft elongation rate and new hair growth and increasing expression of genes contributing to hair growth in dermal papilla cells and promoting hair shaft growth at head hair, beard, eyebrows, and/or eyelashes, these are made to contain an active ingredient in the form of phytosphingosine.

Abstract: The present invention relates to a compound or a pharmacologically acceptable salt thereof having excellent tissue non-specific alkaline phosphatase inhibitory activity. The present invention provides a compound represented by the following formula (I): wherein X1 represents a nitrogen atom or CR9, R1 represents a hydrogen atom, a C1-C6 alkyl group, or a C1-C6 alkoxy group, R2 represents a halogen atom, R3 represents a hydrogen atom or a halogen atom, R4 represents a hydrogen atom or a halogen atom, and R5 represents a C1-C3 alkylsulfonyl group, a substituted C1-C6 alkyl group, a substituted C1-C6 haloalkyl group, a substituted C1-C6 alkoxy group, or a substituted C1-C6 alkylamino group, or a pharmacologically acceptable salt thereof.

Abstract: A gate insulating film has a multilayer structure including a SiO2 film, a LaAlO3 film, and an Al2O3 film that are sequentially stacked, relative permittivity of the gate insulating film being optimized by the LaAlO3 film. In forming the LaAlO3 film constituting the gate insulating film, a La2O3 film and an Al2O3 film are alternately deposited repeatedly using an ALD method. The La2O3 film is deposited first, whereby during a POA performed thereafter, a sub-oxide of the surface of the SiO2 film is removed by a cleaning effect of lanthanum atoms in the La2O3 film. A temperature of the POA is suitably set in a range from 700 degrees C. to less than 900 degrees C.

Abstract: The present invention relates to a novel fused ring compound having urea structure that exhibits excellent NAMPT activating effect, and a method using the same for treating/preventing metabolic disorder, cardiovascular and kidney disease, mitochondrial disease, neurodegenerative disease, ocular disease, and muscle wasting disorder. The present invention provides a compound represented by following formula (I) or a pharmacologically acceptable salt: Formula (I) wherein A, B, R, R2 and R3 represent the same meanings as in the claims.

Abstract: A p++-type outer peripheral contact region is provided in an edge termination region and surrounds a periphery of an active region in a rectangular shape having rounded corners, in a plan view. The p++-type outer peripheral contact region faces a gate runner on a front surface of a semiconductor substrate via an insulating layer. In the active region, a p++-type region is provided facing a gate pad on the front surface of the semiconductor substrate via the insulating layer. The p++-type outer peripheral contact region and the p++-type region are provided apart from p++-type contact regions that form source contacts with a source electrode. The p++-type contact regions and contact holes in which the source contacts are formed are disposed in a uniform layout spanning an entire area of the active region so that an end side and a center side of the active region have the same layout.

Abstract: An AlSi electrode containing an aluminum alloy that contains silicon is sputtered on a surface of a semiconductor substrate that contains silicon carbide. Si nodules having a dendrite structure precipitate in AlSi electrode. At least some of the Si nodules have a dendrite structure, and the rest of the Si nodules have a prismatic structure. A height of the Si nodules having either dendrite structures or prismatic structures in the AlSi electrode in a thickness direction of the AlSi electrode is not more than 2 ?m. A height of the Si nodules having the dendrite structures in the AlSi electrode, preferably, may be 1 ?m or less. A solid solubility of silicon in the AlSi electrode is in a range of 0.3 wt % to 1.59 wt %. A sputtering temperature of the AlSi electrode is in a range of 430 degrees C. to 577 degrees C.

Abstract: P++-type contact regions are disposed apart from one another, and in a p?-type base region, at least hole current regions directly beneath the contact regions have an impurity concentration of not more than 5×1016/cm3. A p+-type region for mitigating electric field and disposed between adjacent gate trenches is separated into first portions in contact with the hole current regions and second portions in contact with only a portion of the base region other than the hole current regions. During conduction of body diodes, forward current flows into an n?-type drain region through the contact regions, the hole current regions, and the first portions. Thus, in the drain region, holes from the base region are injected only into hole injection regions that are directly beneath the first portions, but are not injected into regions that respectively surround peripheries of the hole injection regions.

Abstract: A composition includes: a polymer including a repeating unit represented by formula (1); and a solvent. In the formula (1), Ar1 is a divalent group including an aromatic ring having 10 to 40 ring atoms; and R0 is a monovalent group including a heteroaromatic ring which includes a sulfur atom as a ring-forming atom.

Abstract: A composition includes: a polymer including a repeating unit represented by formula (1); and a solvent. In the formula (1), Ar1 is a divalent group including an aromatic ring having 5 to 40 ring atoms; and R0 is a group represented by formula (1-1) or (1-2). In the formulas (1-1) and (1-2), X1 and X2 are each independently a group represented by formula (i), (ii), (iii) or (iv); * is a bond with the carbon atom in the formula (1); and Ar2, Ar3 and Ar4 are each independently a substituted or unsubstituted aromatic ring having 6 to 20 ring atoms that forms a fused ring structure together with the two adjacent carbon atoms in the formulas (1-1) and (1-2).